HealthPrize Technologies, a Norwalk, CT-based provider of digital health solutions for medication adherence and patient engagement, raised $3m in funding.
The round was led by private equity firm Mansa Capital. As part of the deal, Ruben King-Shaw Jr., Mansa Capital Managing Partner and Chief Investment Officer, will join the HealthPrize board of directors.
The company intends to use the funds to expand the team and grow internationally and into other healthcare verticals.
Led by Thomas Kottler, CEO, HealthPrize creates and manages customized digital patient engagement and adherence programs across diverse medical conditions and demographic groups. Its platform leverages a combination of behavioral economics concepts, gamification, education and rewards to maximize motivational impact.
Current customers are global pharmaceutical companies, including a number of top-20 global pharmaceutical companies, with plans to expand into other healthcare verticals including the payer and retail pharmacy markets as well as risk bearing provider groups and self-insured employers.
FinSMEs
20/08/2014